Abstract PO4-04-02: Real-world first line use of trastuzumab biosimilar (HLX02), pertuzumab and chemotherapy for Chinese patients with HER2-positive metastatic breast cancer
Authors: Ruyan Zhang, Guohong Song, Xiaoran Liu, Hui-Ping Li
Published: 2024-05-02
DOI:
10.1158/1538-7445.sabcs23-po4-04-02
Source:
Full article
Abstract
Abstract